ACAD250919C00030000 Option on ACADIA Pharmaceuticals

An 'Out of The Money' option on ACADIA has a strike price that ACADIA Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for ACADIA Pharmaceuticals' 'Out of The Money' options include buying the options if you expect a big move in ACADIA Pharmaceuticals' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

ACADIA Pharmaceuticals' Option Greeks for the contract ending on 2025-09-19 at a strike price of 30.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to ACADIA Pharmaceuticals' option greeks, its implied volatility helps estimate the risk of ACADIA Pharmaceuticals stock implied by the prices of the options on ACADIA Pharmaceuticals' stock.

Put options written on ACADIA Pharmaceuticals grant holders of the option the right to sell a specified amount of ACADIA Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of ACADIA Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on ACADIA Pharmaceuticals is like buying insurance aginst ACADIA Pharmaceuticals' downside shift.

By selling ACADIA Pharmaceuticals' put option, the investors signal their bearish sentiment. A short position in a put option written on ACADIA Pharmaceuticals will generally make money when the underlying price is above the strike price. Therefore ACADIA Pharmaceuticals' put payoff at expiration depends on where the ACADIA Stock price is relative to the put option strike price. The breakeven price of 30.58 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to ACADIA Pharmaceuticals' price. Finally, at the strike price of 30.0, the payoff chart is constant and positive.

ACADIA Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on ACADIA. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ACADIA. It also shows strike prices and maturity days for a ACADIA Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ACADIA Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.